chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Feeling cold, Hyperhidrosis
Clinical narrative: She started sweating; Chills; Started to shiver,; Very cold; Temperature of 101.7; Nausea; Sore muscles in her neck; fatigue; a little sneezing; Coughing; fast heart beat; Fever went down to 99.3degrees; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), CHILLS (Started to shiver,), FEELING COLD (Very cold), PYREXIA (Temperature of 101.7) and NAUSEA (Nausea) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for an unknown indication. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included No adverse event.   On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 01-Mar-2021, the patient experienced CHILLS (Chills), CHILLS (Started to shiver,), FEELING COLD (Very cold), PYREXIA (Temperature of 101.7), NAUSEA (Nausea), NECK PAIN (Sore muscles in her neck), FATIGUE (fatigue), SNEEZING (a little sneezing), COUGH (Coughing), PALPITATIONS (fast heart beat) and PYREXIA (Fever went down to 99.3degrees). On 02-Mar-2021, the patient experienced HYPERHIDROSIS (She started sweating).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was unknown.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Neck pain, Palpitations, Pyrexia, Sneezing
Clinical narrative: She started sweating; Chills; Started to shiver,; Very cold; Temperature of 101.7; Nausea; Sore muscles in her neck; fatigue; a little sneezing; Coughing; fast heart beat; Fever went down to 99.3degrees; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), CHILLS (Started to shiver,), FEELING COLD (Very cold), PYREXIA (Temperature of 101.7) and NAUSEA (Nausea) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for an unknown indication. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included No adverse event.   On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 01-Mar-2021, the patient experienced CHILLS (Chills), CHILLS (Started to shiver,), FEELING COLD (Very cold), PYREXIA (Temperature of 101.7), NAUSEA (Nausea), NECK PAIN (Sore muscles in her neck), FATIGUE (fatigue), SNEEZING (a little sneezing), COUGH (Coughing), PALPITATIONS (fast heart beat) and PYREXIA (Fever went down to 99.3degrees). On 02-Mar-2021, the patient experienced HYPERHIDROSIS (She started sweating).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza, Influenza virus test, Product dose omission issue, SARS-CoV-2 test
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (flu-like symptoms) and PRODUCT DOSE OMISSION ISSUE (2nd shot of vaccine not received >42 days) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced INFLUENZA (flu-like symptoms) and PRODUCT DOSE OMISSION ISSUE (2nd shot of vaccine not received >42 days). On 02-Feb-2021, PRODUCT DOSE OMISSION ISSUE (2nd shot of vaccine not received >42 days) had resolved. On 10-Feb-2021, INFLUENZA (flu-like symptoms) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Influenza virus test: negative (Negative) Negative. On 04-Feb-2021, SARS-CoV-2 test: negative (Negative) Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. Treatment information was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes
Clinical narrative: Cold sore; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Cold sore) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ORAL HERPES (Cold sore). At the time of the report, ORAL HERPES (Cold sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included eye drops for glaucoma and blood pressure medication Treatment information was unknown.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Product availability issue
Clinical narrative: Intermittent asthma; Vaccine availability issue; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Intermittent asthma) and PRODUCT AVAILABILITY ISSUE (Vaccine availability issue) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced ASTHMA (Intermittent asthma) and PRODUCT AVAILABILITY ISSUE (Vaccine availability issue). At the time of the report, ASTHMA (Intermittent asthma) and PRODUCT AVAILABILITY ISSUE (Vaccine availability issue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications were not provided. The reporter stated that that she had intermittent asthma, did not clarified if it before or after receiving the vaccine. Treatment details were not provided.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Company Comment  Very little information was received for this case. The patient declined follow-up so no new information is expected. Based on current available information it is unclear if the patient actually received the vaccine and if the event was an ongoing, pre-existing condition.   Reporter did not allow further contact; Sender's Comments: Very little information was received for this case. The patient declined follow-up so no new information is expected. Based on current available information it is unclear if the patient actually received the vaccine and if the event was an ongoing, pre-existing condition.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Injection site hypersensitivity
Clinical narrative: arm sensitivity; had some side effects that are on your package insert; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE HYPERSENSITIVITY (arm sensitivity) and ADVERSE EVENT (had some side effects that are on your package insert) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE HYPERSENSITIVITY (arm sensitivity) and ADVERSE EVENT (had some side effects that are on your package insert). At the time of the report, INJECTION SITE HYPERSENSITIVITY (arm sensitivity) and ADVERSE EVENT (had some side effects that are on your package insert) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension
Clinical narrative: High blood pressure than normal; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure than normal) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event and Bypass surgery.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced HYPERTENSION (High blood pressure than normal). At the time of the report, HYPERTENSION (High blood pressure than normal) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was unknown.    This case was linked to MOD21-043200 (E2B Linked Report).; Sender's Comments:  MOD21-043200:same reporter, wife case
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Paraesthesia oral, Pruritus, Rash pruritic
Clinical narrative: little bit itching, little bit of rash on face, both arms and legs; Itching in face; Tingling in mouth and tounge and worked its way down to legs; Tingling down the legs; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching in face), PARAESTHESIA ORAL (Tingling in mouth and tounge and worked its way down to legs), PARAESTHESIA (Tingling down the legs) and RASH PRURITIC (little bit itching, little bit of rash on face, both arms and legs) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PRURITUS (Itching in face), PARAESTHESIA ORAL (Tingling in mouth and tounge and worked its way down to legs) and PARAESTHESIA (Tingling down the legs). On 19-Mar-2021, the patient experienced RASH PRURITIC (little bit itching, little bit of rash on face, both arms and legs). At the time of the report, PRURITUS (Itching in face), PARAESTHESIA ORAL (Tingling in mouth and tounge and worked its way down to legs), PARAESTHESIA (Tingling down the legs) and RASH PRURITIC (little bit itching, little bit of rash on face, both arms and legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 01-Mar-2021: New events were updated.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Left arm was sore after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Left arm was sore after the first dose) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Left arm was sore after the first dose). At the time of the report, PAIN IN EXTREMITY (Left arm was sore after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment included Tylenol and Claritin   This case was linked to MOD-2021-032604.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Malaise, Vaccination site pain
Clinical narrative: Concurrent medical conditions included Blood pressure abnormal and Thyroid disorder NOS. Concomitant products included VITAMINS NOS for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced MALAISE (Didn't feel good), HEADACHE (headache), VACCINATION SITE PAIN (pain in my arm of injection), FATIGUE (tiredness) and LYMPHADENOPATHY (Swelling of lymph nodes under arm of injection (left arm)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (Didn't feel good), HEADACHE (headache), VACCINATION SITE PAIN (pain in my arm of injection), FATIGUE (tiredness) and LYMPHADENOPATHY (Swelling of lymph nodes under arm of injection (left arm)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications also reported were Blood pressure medicine, Thyroid medicine.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity, Vaccination site pain
Clinical narrative: Patient is not tired but looks tired; Patient experienced severe squeezing headache after receiving 2nd dose and still not going away; Patient reported pain in injection site; sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Patient reported pain in injection site), HEADACHE (Patient experienced severe squeezing headache after receiving 2nd dose and still not going away), FATIGUE (Patient is not tired but looks tired) and PAIN IN EXTREMITY (sore left arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ALENDRONATE SODIUM (ALENDRONATE) for an unknown indication.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 24-Jan-2021, the patient experienced VACCINATION SITE PAIN (Patient reported pain in injection site) and PAIN IN EXTREMITY (sore left arm). On 20-Feb-2021, the patient experienced HEADACHE (Patient experienced severe squeezing headache after receiving 2nd dose and still not going away). On 02-Mar-2021, the patient experienced FATIGUE (Patient is not tired but looks tired).   The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. On 26-Jan-2021, VACCINATION SITE PAIN (Patient reported pain in injection site) and PAIN IN EXTREMITY (sore left arm) had resolved. At the time of the report, HEADACHE (Patient experienced severe squeezing headache after receiving 2nd dose and still not going away) and FATIGUE (Patient is not tired but looks tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient is treated with Advil.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Additional information added.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Disorientation, Feeling abnormal, Feeling cold
Clinical narrative: moderate sore arm; all hell broke loose; arm swollen; muscle that goes down the front of arm is also sore; hard to raise her arm; hurt too much to raise her arm; chills; shaking; threw up; stomch upset; freezing; could not get warm; teeth was shaking; became so disoriented that she was not capable figuring how to call her husband; running a feve; fever was 117; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (moderate sore arm), FEELING ABNORMAL (all hell broke loose), VACCINATION SITE SWELLING (arm swollen), MYALGIA (muscle that goes down the front of arm is also sore) and VACCINATION SITE MOVEMENT IMPAIRMENT (hard to raise her arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN, WARFARIN, PROPRANOLOL HYDROCHLORIDE (PROPANOLOL BOEHRINGER), BUTALBITAL, CAFFEINE, PARACETAMOL (FIORICET), MONTELUKAST SODIUM (SINGULAIR), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), Nasacort as needed, Supplements and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (moderate sore arm), FEELING ABNORMAL (all hell broke loose), VACCINATION SITE SWELLING (arm swollen), MYALGIA (muscle that goes down the front of arm is also sore), VACCINATION SITE MOVEMENT IMPAIRMENT (hard to raise her arm), VACCINATION SITE PAIN (hurt too much to raise her arm), CHILLS (chills), TREMOR (shaking), VOMITING (threw up), ABDOMINAL DISCOMFORT (stomch upset), FEELING COLD (freezing), FEELING COLD (could not get warm), CHILLS (teeth was shaking), DISORIENTATION (became so disoriented that she was not capable figuring how to call her husband), PYREXIA (running a feve) and PYREXIA (fever was 117). At the time of the report, MYALGIA (moderate sore arm), FEELING ABNORMAL (all hell broke loose), VACCINATION SITE SWELLING (arm swollen), MYALGIA (muscle that goes down the front of arm is also sore), VACCINATION SITE MOVEMENT IMPAIRMENT (hard to raise her arm), VACCINATION SITE PAIN (hurt too much to raise her arm), CHILLS (chills), TREMOR (shaking), VOMITING (threw up), ABDOMINAL DISCOMFORT (stomch upset), FEELING COLD (freezing), FEELING COLD (could not get warm), CHILLS (teeth was shaking), DISORIENTATION (became so disoriented that she was not capable figuring how to call her husband), PYREXIA (running a feve) and PYREXIA (fever was 117) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Tremor, Vaccination site movement impairment, Vaccination site pain
Clinical narrative: moderate sore arm; all hell broke loose; arm swollen; muscle that goes down the front of arm is also sore; hard to raise her arm; hurt too much to raise her arm; chills; shaking; threw up; stomch upset; freezing; could not get warm; teeth was shaking; became so disoriented that she was not capable figuring how to call her husband; running a feve; fever was 117; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (moderate sore arm), FEELING ABNORMAL (all hell broke loose), VACCINATION SITE SWELLING (arm swollen), MYALGIA (muscle that goes down the front of arm is also sore) and VACCINATION SITE MOVEMENT IMPAIRMENT (hard to raise her arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN, WARFARIN, PROPRANOLOL HYDROCHLORIDE (PROPANOLOL BOEHRINGER), BUTALBITAL, CAFFEINE, PARACETAMOL (FIORICET), MONTELUKAST SODIUM (SINGULAIR), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), Nasacort as needed, Supplements and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (moderate sore arm), FEELING ABNORMAL (all hell broke loose), VACCINATION SITE SWELLING (arm swollen), MYALGIA (muscle that goes down the front of arm is also sore), VACCINATION SITE MOVEMENT IMPAIRMENT (hard to raise her arm), VACCINATION SITE PAIN (hurt too much to raise her arm), CHILLS (chills), TREMOR (shaking), VOMITING (threw up), ABDOMINAL DISCOMFORT (stomch upset), FEELING COLD (freezing), FEELING COLD (could not get warm), CHILLS (teeth was shaking), DISORIENTATION (became so disoriented that she was not capable figuring how to call her husband), PYREXIA (running a feve) and PYREXIA (fever was 117). At the time of the report, MYALGIA (moderate sore arm), FEELING ABNORMAL (all hell broke loose), VACCINATION SITE SWELLING (arm swollen), MYALGIA (muscle that goes down the front of arm is also sore), VACCINATION SITE MOVEMENT IMPAIRMENT (hard to raise her arm), VACCINATION SITE PAIN (hurt too much to raise her arm), CHILLS (chills), TREMOR (shaking), VOMITING (threw up), ABDOMINAL DISCOMFORT (stomch upset), FEELING COLD (freezing), FEELING COLD (could not get warm), CHILLS (teeth was shaking), DISORIENTATION (became so disoriented that she was not capable figuring how to call her husband), PYREXIA (running a feve) and PYREXIA (fever was 117) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vomiting
Clinical narrative: moderate sore arm; all hell broke loose; arm swollen; muscle that goes down the front of arm is also sore; hard to raise her arm; hurt too much to raise her arm; chills; shaking; threw up; stomch upset; freezing; could not get warm; teeth was shaking; became so disoriented that she was not capable figuring how to call her husband; running a feve; fever was 117; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (moderate sore arm), FEELING ABNORMAL (all hell broke loose), VACCINATION SITE SWELLING (arm swollen), MYALGIA (muscle that goes down the front of arm is also sore) and VACCINATION SITE MOVEMENT IMPAIRMENT (hard to raise her arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN, WARFARIN, PROPRANOLOL HYDROCHLORIDE (PROPANOLOL BOEHRINGER), BUTALBITAL, CAFFEINE, PARACETAMOL (FIORICET), MONTELUKAST SODIUM (SINGULAIR), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), Nasacort as needed, Supplements and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (moderate sore arm), FEELING ABNORMAL (all hell broke loose), VACCINATION SITE SWELLING (arm swollen), MYALGIA (muscle that goes down the front of arm is also sore), VACCINATION SITE MOVEMENT IMPAIRMENT (hard to raise her arm), VACCINATION SITE PAIN (hurt too much to raise her arm), CHILLS (chills), TREMOR (shaking), VOMITING (threw up), ABDOMINAL DISCOMFORT (stomch upset), FEELING COLD (freezing), FEELING COLD (could not get warm), CHILLS (teeth was shaking), DISORIENTATION (became so disoriented that she was not capable figuring how to call her husband), PYREXIA (running a feve) and PYREXIA (fever was 117). At the time of the report, MYALGIA (moderate sore arm), FEELING ABNORMAL (all hell broke loose), VACCINATION SITE SWELLING (arm swollen), MYALGIA (muscle that goes down the front of arm is also sore), VACCINATION SITE MOVEMENT IMPAIRMENT (hard to raise her arm), VACCINATION SITE PAIN (hurt too much to raise her arm), CHILLS (chills), TREMOR (shaking), VOMITING (threw up), ABDOMINAL DISCOMFORT (stomch upset), FEELING COLD (freezing), FEELING COLD (could not get warm), CHILLS (teeth was shaking), DISORIENTATION (became so disoriented that she was not capable figuring how to call her husband), PYREXIA (running a feve) and PYREXIA (fever was 117) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Fatigue; Headache; Fever; Chills; Body aches; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches) and ARTHRALGIA (Joint pain). At the time of the report, FATIGUE (Fatigue), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches) and ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitants and treatment were not reported.   This case was linked to MOD-2021-032628 (Patient Link).   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fatigue; Headache; Fever; Chills; Body aches; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced FATIGUE (Fatigue), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches) and ARTHRALGIA (Joint pain). At the time of the report, FATIGUE (Fatigue), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches) and ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitants and treatment were not reported.   This case was linked to MOD-2021-032628 (Patient Link).   Reporter did not allow further contact
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Insomnia, Pain
Clinical narrative: Couldn't sleep; in a lot of pain; whole body feels like pain from a serious back injury; Feels like hit on head with a baseball bat; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Couldn't sleep), HEADACHE (Feels like hit on head with a baseball bat), PAIN (in a lot of pain) and PAIN (whole body feels like pain from a serious back injury) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced INSOMNIA (Couldn't sleep), HEADACHE (Feels like hit on head with a baseball bat), PAIN (in a lot of pain) and PAIN (whole body feels like pain from a serious back injury). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Headache and Pain, at an unspecified dose and frequency. At the time of the report, INSOMNIA (Couldn't sleep), HEADACHE (Feels like hit on head with a baseball bat), PAIN (in a lot of pain) and PAIN (whole body feels like pain from a serious back injury) outcome was unknown.            No concomitant medications details were not reported.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Antibody test, Chills, Pyrexia
Clinical narrative: Chills; Fever; This spontaneous case was reported by an other health care professional and describes the occurrence of CHILLS (Chills) and PYREXIA (Fever) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced CHILLS (Chills) and PYREXIA (Fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 04-Feb-2021, CHILLS (Chills) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Feb-2021, Antibody test: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache
Clinical narrative: Not feeling herself; Patient is not tired but looks tired; Severe squeezing headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Not feeling herself), HEADACHE (Severe squeezing headache) and FATIGUE (Patient is not tired but looks tired) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 026L20A) for COVID-19 vaccination.     The patient's past medical history included Osteoporosis. Concomitant products included IBUPROFEN from 20-Feb-2021 to 20-Feb-2021 for Headache, ALENDRONATE SODIUM (ALENDRONATE) for Osteoporosis, MULTIVITAMIN [VITAMINS NOS], MAGNESIUM, VITAMIN D3, FISH OIL and BIOTIN for an unknown indication.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced HEADACHE (Severe squeezing headache). On 02-Mar-2021, the patient experienced FEELING ABNORMAL (Not feeling herself) and FATIGUE (Patient is not tired but looks tired). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Not feeling herself) and FATIGUE (Patient is not tired but looks tired) outcome was unknown and HEADACHE (Severe squeezing headache) had not resolved.            This case was linked to MOD-2021-032624 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow up received on 3-5-2021, Patient demographics, medical history, concomitants updated
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Herpes zoster, Pain in extremity, Pruritus, Pyrexia
Clinical narrative: Arms were sore; Kind of itched; it was hot; shingles on left arm; another place of the exact kind of redness appeared; It turned red; Feverish; there was a knot there; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arms were sore), PRURITUS (Kind of itched), ERYTHEMA (another place of the exact kind of redness appeared), VACCINATION SITE WARMTH (it was hot) and HERPES ZOSTER (shingles on left arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037L20A and 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chickenpox, Arthritis and Accident (whiplash from a car accident 40 years ago.).   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Dec-2020, the patient experienced VACCINATION SITE ERYTHEMA (It turned red) and PYREXIA (Feverish). On 03-Jan-2021, the patient experienced ERYTHEMA (another place of the exact kind of redness appeared). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arms were sore), PRURITUS (Kind of itched), VACCINATION SITE WARMTH (it was hot), HERPES ZOSTER (shingles on left arm) and VACCINATION SITE INDURATION (there was a knot there). On 02-Jan-2021, PYREXIA (Feverish) had resolved. On 07-Jan-2021, VACCINATION SITE ERYTHEMA (It turned red) had resolved. On 13-Jan-2021, ERYTHEMA (another place of the exact kind of redness appeared) had resolved. At the time of the report, PAIN IN EXTREMITY (Arms were sore), VACCINATION SITE WARMTH (it was hot) and VACCINATION SITE INDURATION (there was a knot there) had resolved, PRURITUS (Kind of itched) outcome was unknown and HERPES ZOSTER (shingles on left arm) had not resolved.            No concomitant medications were reported. Treatment information included antivirals for shingles.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Reporter's contact details was added, updated the event, duration and outcome of event.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site warmth
Clinical narrative: Arms were sore; Kind of itched; it was hot; shingles on left arm; another place of the exact kind of redness appeared; It turned red; Feverish; there was a knot there; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arms were sore), PRURITUS (Kind of itched), ERYTHEMA (another place of the exact kind of redness appeared), VACCINATION SITE WARMTH (it was hot) and HERPES ZOSTER (shingles on left arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037L20A and 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chickenpox, Arthritis and Accident (whiplash from a car accident 40 years ago.).   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Dec-2020, the patient experienced VACCINATION SITE ERYTHEMA (It turned red) and PYREXIA (Feverish). On 03-Jan-2021, the patient experienced ERYTHEMA (another place of the exact kind of redness appeared). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arms were sore), PRURITUS (Kind of itched), VACCINATION SITE WARMTH (it was hot), HERPES ZOSTER (shingles on left arm) and VACCINATION SITE INDURATION (there was a knot there). On 02-Jan-2021, PYREXIA (Feverish) had resolved. On 07-Jan-2021, VACCINATION SITE ERYTHEMA (It turned red) had resolved. On 13-Jan-2021, ERYTHEMA (another place of the exact kind of redness appeared) had resolved. At the time of the report, PAIN IN EXTREMITY (Arms were sore), VACCINATION SITE WARMTH (it was hot) and VACCINATION SITE INDURATION (there was a knot there) had resolved, PRURITUS (Kind of itched) outcome was unknown and HERPES ZOSTER (shingles on left arm) had not resolved.            No concomitant medications were reported. Treatment information included antivirals for shingles.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Reporter's contact details was added, updated the event, duration and outcome of event.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: second dose in the series appointment was cancelled, rescheduled appointment is 60 days later after initial dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose in the series appointment was cancelled, rescheduled appointment is 60 days later after initial dose) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included DIMETHYL FUMARATE (TECFIDERA) for Multiple sclerosis.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose in the series appointment was cancelled, rescheduled appointment is 60 days later after initial dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose in the series appointment was cancelled, rescheduled appointment is 60 days later after initial dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Second dose in the series appointment was cancelled, rescheduled appointment is 60 days later after initial dose. No treatment information was reported.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: UTI; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included UTI (recently hospitalized for it on 12JAN2021.).    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced URINARY TRACT INFECTION (UTI). At the time of the report, URINARY TRACT INFECTION (UTI) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Emergency care, Fall, Myalgia, SARS-CoV-2 test
Clinical narrative: falling down; went to the ER were they were put on an IV; body chills; body aches; This spontaneous case was reported by a physician and describes the occurrence of FALL (falling down), EMERGENCY CARE (went to the ER were they were put on an IV), CHILLS (body chills) and MYALGIA (body aches) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included Cardiac disorder (con med: 4 different medication for a heart problem they had on 1990) in 1990 and COVID-19 in November 2020.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced FALL (falling down), EMERGENCY CARE (went to the ER were they were put on an IV), CHILLS (body chills) and MYALGIA (body aches). On 01-Mar-2021, FALL (falling down), EMERGENCY CARE (went to the ER were they were put on an IV), CHILLS (body chills) and MYALGIA (body aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details included Tylenol, IV at the ER  concomitant medicines include 4 different medication for a heart problem  had on 1990  Action taken with mRNA-1273 in response to the event was unknown
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: swollen arm; arm hurt; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm) and PAIN IN EXTREMITY (arm hurt) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Guillain-Barre syndrome.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen arm) and PAIN IN EXTREMITY (arm hurt). At the time of the report, PERIPHERAL SWELLING (swollen arm) and PAIN IN EXTREMITY (arm hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, Vaccination site discharge
Clinical narrative: This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of ACCIDENTAL UNDERDOSE (More than half of the dose was administered) and VACCINATION SITE DISCHARGE (Vaccination site discharge) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 02-Mar-2021, the patient experienced ACCIDENTAL UNDERDOSE (More than half of the dose was administered). On an unknown date, the patient experienced VACCINATION SITE DISCHARGE (Vaccination site discharge). At the time of the report, ACCIDENTAL UNDERDOSE (More than half of the dose was administered) had resolved and VACCINATION SITE DISCHARGE (Vaccination site discharge) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Reporter's Comments: This report refers to a case of Accidental under-dose and Vaccination site discharge for mRNA-1273 (lot# 013A21A) with no associated adverse events.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever of 102.1; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 102.1) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced PYREXIA (fever of 102.1). At the time of the report, PYREXIA (fever of 102.1) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: 102.1 degree Celsius High.         No relevant concomitant medications were reported. Treatment details included Not provided.
Sex: F
Vaccine: COVID19
Symptoms: Product administered at inappropriate site, Vaccination site erythema
Clinical narrative: Vaccine given halfway down her arm; she has a large red mark around the vaccine site; A spontaneous report was received from a consumer concerning a 72-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273).  The patient's medical history, as provided by the reporter, included autoimmune condition (Polymyalgia Rheumatica) and a pulmonary condition (Pulmonary Fibrosis). Concomitant medication included prednisone.   On 31 Jan 2021, the patient received her first of two planned doses of mRNA-1273 (Lot number: 039K2CA) intramuscularly for prophylaxis of COVID-19 infection.   On 01 Mar 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (Lot number: 010A21A) subcutaneously for prophylaxis of COVID-19 infection.   On an unspecified day in Mar-2021, after receiving the second dose  the patient noticed a large red mark around the vaccine site and she believe the vaccine was given halfway down her arm. There was no treatment information provided.  Action taken with mRNA-1273 in response to the events is not applicable.  The outcome of the event vaccination site erythema was unknown.  .; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Type IV hypersensitivity reaction
Clinical narrative: COVID arm - a big red area, size of palm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (COVID arm - a big red area, size of palm at injection site) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (COVID arm - a big red area, size of palm at injection site). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (COVID arm - a big red area, size of palm at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.